However, one issue in this regard is that the involvement of some mito E3 in cancer has not yet been investigated, especially when they share a target of ubiquitination (such as MFN2, ubiquitinated by both MARCH5 and MUL1) or when they are associated with the same cellular process (such as the ERAD mechanism). The gene discussed is MFN2; the disease is cancer.